Welcome : Guest

Granules India Ltd. (India) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Granules India Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 62 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-25504
Price: $3100
Company Type: Public
Pages: 65
Date: November 2016
Market Data Tables: 62

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Granules India Ltd.'s (Operations) Sales by Product Segment Worldwide (2015-2016) in Percentage for Paracetemol, Metformin, Ibuprofin, Guaifenesin, Methocarbamol, and Others......4
Table 2: Granules India Ltd.'s (Operations) Sales by Geographical Region Worldwide (2015-2016) in Percentage for North America, Europe, Latin America, India, and Rest of the World......5
Table 3: Granules India Ltd.’s (Operations) Sales by Geographic Region Worldwide (2014-2015) in Rs Lakhs for India and International......6
Pharmaceuticals......7
Table 4: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......7
Generic Pharmaceuticals......8
Table 5: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......8
Active Pharmaceutical Ingredients (API)......9
Table 6: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......9
Table 7: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......10
Table 8: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......11
Table 9: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......12
Table 10: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......13
Narcotic Drugs......14
Table 11: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......14
Diabetes Drugs......15
Table 12: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......15
Table 13: Diabetes Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Delivery Devices, Glucose Monitoring, Insulin, and Oral Medication......16
Table 14: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others......17
Table 15: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......18
Table 16: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......19
Table 17: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......20
Table 18: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......21
Table 19: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......22
Table 20: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......23
Table 21: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......24
Table 22: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......25
Table 23: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......26
Table 24: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......27
Table 25: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......28
Table 26: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......29
Table 27: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......30
Table 28: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......31
Table 29: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......32
Table 30: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......33
Table 31: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......34
Table 32: Diagnosed Narcolepsy Patients Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Current Xyrem Patient, Untreated Diagnosed Patients and WF Peak Additional Xyrem Patients......35
Oral Diabetes Medicine......36
Table 33: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......36
DPP-4 Inhibitors......37
Table 34: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......37
Table 35: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......38
Table 36: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......39
Pharmaceuticals Prescriptions......40
Table 37: Pharmaceuticals Prescription Market by Product in the US (2015) - Percentage Share Breakdown by Value Sales for Amlodipine, Hydrocodone/Acetaminophen, Levothyroxine, Lisinopril, Metformin, Metoprolol, Omeprazole, Salbutamol, Simvastatin, and Others......40
Analgesic Molecules......41
Table 38: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......41
Narcotic Drugs......42
Table 39: Market Shares of Leading Narcotic Drugs Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Beijing Mundipharma Ltd., China National Medicines Corporation, Impofstoffwerk Dessau Tomau GmbH, Notheast Pharmaceutical Group ., Ltd., Shanhaiguan Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., The Grunenthal Group, Weihal Lotus Pharmaceutical Co., Ltd., Wuhan HumanWell Bi-Tech Industry Co., Ltd., Xian-Janseen Pharmaceutical Ltd., and Others......42
Ibuprofen Suspension......43
Table 40: Market Shares of Leading Ibuprofen Suspension Brands in the US (2015) - Percentage Share Breakdown by Volume for Children’s Advil (PFE), Children’s Motrin (JNJ), and Private Label Ibuprofen Suspension (ACT and PRGO)......43
Table 41: Market Shares of Leading Ibuprofen Drop Brands the US (2015) - Percentage Share Breakdown by Volume for Infant Advil (PFE), Private Label Infant Ibuprofen Drops (ACT and PRGO), and Others......44
Table 42: Market Shares of Leading Pediatric Liquid Ibuprofen Brands in the US (2015) -Percentage Share Breakdown by Volume for Advil (PFE), Motrin (JNJ), and Others......45
Table 43: Market Shares of Leading Ibuprofen Suppliers Worldwide (2015) - Percentage Share Breakdown by Value for Albemarle, BASF PharmaChemikalien GmbH & Co. KG, Hubei Granules-Biocause Pharmaceuticals Co., Ltd., IOL Chemical and Pharmaceuticals Ltd., Shasun Pharmaceuticals Limited and Others......46
Paracetamol......47
Table 44: Market Shares of Leading Paracetamol Suppliers Worldwide (2015) - Percentage Share Breakdown by Value for Granules India Limited, Mallinckrodt Pharmaceuticals and Novocol Pharmaceutical of Canada, Inc.......47
Methocarbamol......48
Table 45: Market Shares of Leading Methocarbamol Suppliers in India (2015) - Percentage Share Breakdown by Value for Granules India Limited, Synthochem Labs Pvt. Ltd and Others......48
Guaifenesin......49
Table 46: Market Shares of Leading Guaifenesin Suppliers in India (2015) - Percentage Share Breakdown by Value for Granules India Limited, Synthochem Labs Pvt. Ltd and Others......49
Diabetes Drugs......50
Table 47: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......50
Table 48: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......51
Table 49: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......52
Metformin......53
Table 50: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......53
Sitagliptin/Metformin......54
Table 51: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......54
Table 52: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......55
Vildagliptin/Metformin......56
Table 53: Market Shares of Leading Vildagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Novartis India Ltd., USV Pvt Ltd., and Others......56
Table 54: Market Shares of Leading Vildagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Galvus Met, Jalra M, and Others......57
DPP-4 Inhibitors......58
Table 55: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......58
Table 56: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......59
Table 57: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......60
Table 58: Market Shares of Leading DPP-4 Drugs Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Merck & Co., Inc., Novartis AG, and Others......61
Table 59: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......62
Table 60: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......63
Table 61: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......64
Table 62: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......65